These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22546532)

  • 1. Oral acetazolamide after Boston keratoprosthesis in Stevens-Johnson syndrome.
    Kumar R; Dohlman CH; Chodosh J
    BMC Res Notes; 2012 Apr; 5():205. PubMed ID: 22546532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma with modified osteo-odonto keratoprosthesis.
    Iyer G; Srinivasan B
    Cornea; 2012 Sep; 31(9):1092. PubMed ID: 22699560
    [No Abstract]   [Full Text] [Related]  

  • 4. Stevens-Johnson syndrome induced by acetazolamide.
    Her Y; Kil MS; Park JH; Kim CW; Kim SS
    J Dermatol; 2011 Mar; 38(3):272-5. PubMed ID: 21342230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and acetazolamide.
    Yu JF; Liang L; Huang YF
    J Glaucoma; 2010; 19(8):568; author reply 568. PubMed ID: 20948389
    [No Abstract]   [Full Text] [Related]  

  • 7. Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome.
    Basu S; Sureka S; Shukla R; Sangwan V
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24663249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report.
    Ogasawara K; Tomitsuka N; Kobayashi M; Komoribayashi N; Fukuda T; Saitoh H; Inoue T; Ogawa A
    Neurol Med Chir (Tokyo); 2006 Mar; 46(3):161-3. PubMed ID: 16565588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
    Su JR; Haber P; Ng CS; Marquez PL; Dores GM; Perez-Vilar S; Cano MV
    Vaccine; 2020 Feb; 38(7):1746-1752. PubMed ID: 31870573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
    Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
    Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.